Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Acute Myeloid Leukemia - Sunesis Completes Enrollment of Voreloxin REVEAL-1 Trial in Acute Myeloid Leukemia
Celldex Therapeutics - Celldex Therapeutics Presents Positive Clinical Data from Phase 1 Studies of Antibody-Based Cancer Vaccine Candidate, CDX-1307
Glioblastoma - Ascenta Therapeutics Announces Presentation of Results From a Dose-Ranging Study of AT-101 With Standard Therapy in Patients With Glioblastoma Multiforme
Obesity - Additional Data from the Qnexa Phase 3 Studies Presented at the Obesity Society 27th Annual Scientific Meeting
Acute Myeloid Leukemia - Studies from A.D. Schimmer et al further understanding of acute myeloid leukemia
Alopecia Areata - Studies from University of Texas update current data on alopecia areata
Cancer Vaccines - New findings reported from V.T. Ho and co-authors describe advances in cancer vaccines
Cancer Vaccines - Researchers at University of Washington target cancer vaccines
Drug Resistance - Studies from Kitasato University have provided new information about drug resistance
Endocrine Research - Studies from A. Rinke et al add new findings in the area of endocrine research
Enzyme Research - Studies from S. Pakola et al in the area of enzyme research described
Glioblastoma - Research from University of Regensburg reveals new findings on glioblastoma
Glioblastoma - Research results from Duke University update knowledge of glioblastoma
Head and Neck Cancer - Research results from University of Texas update understanding of head and neck cancer
Kidney Cancer - Research from University of Kansas has provided new data on kidney cancer
Life Sciences - New data from University of Leeds illuminate research in life sciences
Melanoma - New melanoma study results from University of Texas described
Pancreatic Cancer - Research from Northwestern University, Medical Department provides new data on pancreatic cancer
Poisoning - New findings from University of Peradeniya in the area of poisoning published
Small Cell Lung Cancer - Study results from University of North Carolina provide new insights into small cell lung cancer
Squamous Cell Carcinoma - Research from University of Heidelberg yields new data on squamous cell carcinoma
Surgery - New surgery data have been reported by researchers at University of Florida, Medical Department
Thromboembolism - Research from O.E. Dahl and co-authors reveals new findings on thromboembolism
Transfusion Medicine - Research data from University Hospital update understanding of transfusion medicine
Schizophrenia Therapy - Study results from S. Volpi et al provide new insights into schizophrenia therapy
22nd Century Limited, LLC - 22nd Century Continuing Development of its Smoking Cessation Aid; Independent Review of Clinical Trials Involving Very Low Nicotine Cigarettes is Encouraging
AcelRx Pharmaceuticals, Inc. - AcelRx Announces Successful Completion of End-of-Phase 2 Meeting on ARX-01, Sufentanil NanoTab PCA System for Post-Operative Pain Management
Alkermes, Inc. - Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 37 for the Treatment of Opioid-Induced Constipation
Alzheimer Disease - Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology
Antigenics - Data Presented on Oncophage(R) Cancer Vaccine in Recurrent Glioma at SNO 2009
Antigenics Inc. - Antigenics Reports Third Quarter 2009 Financial Results
Biomoda, Inc. - Biomoda Prepares for Phase III Clinical Trials
Breast Cancer - Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
Cancer Vaccines - Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
Cirrhosis - Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
Constipation - Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
Curis, Inc. - Curis Reports Third Quarter 2009 Financial Results
Curis, Inc. - Curis to Present at the Oppenheimer 20th Annual Healthcare Conference
Depomed, Inc. - Depomed Reports Third Quarter 2009 Financial Results
Drug Resistance - Presentations of Cempra Pharmaceutical's CEM-102 (fusidic acid) at the Infectious Diseases Society of America Annual Meeting Highlight Properties That Make It an Excellent Anti-MRSA Candidate
Elan Corporation plc / Biogen Idec - Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates of Hospitalization in Patients with Moderate-to-Severe Crohn's Disease
Endocyte Inc. - Endocyte Awarded Patent for Vitamin Receptor Binding Drug Delivery Conjugates
Exelixis, Inc. - Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in Patients With the Most Common and Aggressive Form of Brain Cancer
Forest Laboratories, Inc. - Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia
Genta Incorporated - Genta Announces Top-Line Results of AGENDA Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma
Hemophilia A - PTC Therapeutics Initiates Phase 2 Clinical Trial of ataluren (PTC124(R)) in Patients with Hemophilia
Hepatitis C Virus - Difficult-to-Treat Patient Populations Respond Positively to Hepatitis C Treatment
Human Genome Sciences, Inc. - Human Genome Sciences Announces Third Quarter 2009 Financial Results and Key Developments
ImmunoCellular Therapeutics, Ltd. - ImmunoCellular Therapeutics Presents Data from Phase I Trial of ICT-107 Demonstrating Significant Increase in Tumor-Free Progression in Patients with Brain Cancer
ImmunoGen, Inc. - ImmunoGen, Inc. Reports First Quarter Fiscal Year 2010 Financial Results
MannKind Corporation - Studies Show Early Promise of MannKind's Cancer Immunotherapy Program in Melanoma, Prostate Cancer and Other Solid Malignancies
NeoPharm, Inc. - NeoPharm Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Locally Advanced or Metastatic Pancreatic Cancer Patients as a Frontline Treatment
NPS Pharmaceuticals, Inc. - Data Demonstrate That GATTEX(TM) Teduglutide Improves Lean Body Mass, Mineral Composition and Electrolyte Levels in Patients with Parenteral Nutrition Dependent Short Bowel Syndrome
Obesity - New Data From Arena Pharmaceuticals' Pivotal BLOSSOM Trial of Lorcaserin Demonstrate Improvements in Patients' Body Composition, Cardiovascular Risk Factors and Quality of Life
Obesity and Diabetes - Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
Oncolytics Biotech Inc. - Oncolytics Biotech(R) Inc. Collaborators to Present Phase II Sarcoma Trial Results at CTOS Annual Meeting
Ovarian Cancer - Nektar Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial Evaluating NKTR-102 in Patients with Platinum-Resistant Ovarian Cancer
Patents - Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene
Pharmaceuticals - BioCryst Reports Third Quarter 2009 Financial Results and Provides Corporate Update
Pharmaceuticals - Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Third Quarter Financial Results
Promedior, Inc. - European Commission Grants Promedior's PRM-151 Orphan Drug Designation for the Prevention of Scarring Post Glaucoma Filtration Surgery
Therapy - Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
Therapy - Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study
ZymoGenetics, Inc. - ZymoGenetics Initiates Phase 2 Clinical Trial of PEG-Interferon lambda in Hepatitis C with Bristol-Myers Squibb
